You are here

Home » Content

Obez çocuklarda metabolik sendrom prevalansı ve kardiyovasküler risk faktörlerinin sıklığı

The prevalence of metabolic syndrome and frequency of cardiovascular risk factors in obese children

Journal Name:

  • Gülhane Tıp Dergisi

Publication Year:

  • 2010

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Frequency of metabolic syndrome and cardiovascular risk factors were investigated in obese children and adolescents in this study. Two hundred and eight children with a mean age of 9.9±2.5 years were enrolled in the study. WHO criteria were used in the diagnosis of metabolic syndrome. Hypertrigliceridemia, hypercholesterolemia, high LDL cholesterol, low HDL cholesterol, hypertension and impaired glucose tolerance were detected in 66 (31.7%), 30 (14.4%), 26 (12.5%), 7 (3.3%), 34 (16.3%) and 34 (16.3%) of the cases, respectively. The frequency of cardiovascular risk factors was not significantly different between the female and male obese children (p>0.05). Significantly lower HDL cholesterol levels were noted in prepubertal obese children when compared to pubertal obese children (7% and 0%, respectively). Of all the cases, insulin resistance was present in 43.7% (n=91). Metabolic syndrome was detected in 27.4% and 21.4% of male obese and female obese children, respectively. Metabolic syndrome was present in 22 (21.7%) and 30 (28%) of prepubertal obese cases and adolescent obese cases, respectively (p>0.05). Of all the cases, 25% (n=52) had metabolic syndrome. The frequency of metabolic syndrome did not show significant differences between female obese and male obese children, and prepubertal obese and pubertal obese cases (p>0.05). Of the cardiovascular risk factors in the present study, insulin resistance and hypertrigliceridemia were particularly more frequent in obese children and adolescents. The prevalence of metabolic syndrome is high in obese children and adolescents. This situation is a great risk for our children who are the future of our country.
Bookmark/Search this post with
Abstract (Original Language): 
Bu çalışmada, obez çocuk ve adölesanlarda metabolik sendrom ve kardiyovasküler risk faktörlerinin sıklığı araştırıldı. Yaş ortalaması 9.9±2.5 yıl olan 208 obez çocuk değerlendirildi. Metabolik sendrom tanısı için WHO kriterleri kullanıldı. Olguların 66’sında (%31.7) hipertrigliseridemi, 30’unda (%14.4) hiperkolesterolemi, 26’sında (%12.5) LDL-kolesterol yüksekliği, 7’sinde (%3.3) HDL-kolesterol düşüklüğü, 34’ünde (%16.3) hipertansiyon, 34’ünde (%16.3) bozulmuş açlık glikozu saptandı. Kardiyovasküler risk faktörlerinin sıklığı kız ve erkek obezler arasında istatistiksel olarak anlamlı farklılık göstermiyordu (p>0.05). HDL-kolesterol düşüklüğü prepubertal obezlerde pubertal obezlere göre daha sık idi (sırasıyla %7 ve %0, p<0.05). Tüm olguların %43.7’sinde (n=91) insülin direnci vardı. Metabolik sendrom, obez erkek olguların %27.4’ünde, obez kızların %21.4’ünde tespit edildi (p>0.05). Prepubertal olguların 22’sinde (%21.7), adölesan obezlerin ise 30’unda (%28.0) metabolik sendrom saptandı (p>0.05). Tüm olguların ise %25’inde (n=52) metabolik sendrom vardı. Metabolik sendrom sıklığı kız/erkek ve prepubertal/pubertal obezlerde farklılık göstermiyordu (p>0.05). Çalışmamı- zın sonuçlarına göre kardiyovasküler risk faktörlerinden özellikle insülin direnci ile hipertrigliseridemi, obez çocuk ve adölesanlarda oldukça sık görülmektedir. Obez çocuk ve adölesanlarda metabolik sendrom prevalansı yüksektir. Bu durum ülkemizin geleceği olan çocuklarımız için büyük risk oluşturmaktadır.
FULL TEXT (PDF): 
PDF icon arastirmax-obez-cocuklarda-metabolik-sendrom-prevalansi-kardiyovaskuler-risk-faktorlerinin-sikligi.pdf
  • 1
32-35
  • Turkish

REFERENCES

References: 

Kaynaklar
1. Eckel RH. Obesity and heart disease: a statement for
health care professionals from the Nutrition Committee,
American Heart Association. Circulation 1997; 96:
3248-3250.
2. Eckel RH, Barouch WW, Ershow AG. Report of the
National Heart, Lung, and Blood Institute-National
Institute of Diabetes and Digestive and Kidney Diseases
Working Group on the pathophysiology of obesityassociated cardiovascular disease. Circulation 2002; 105:
2923–2928.Cilt 52 • Sayı 1 Obezite ve metabolik sendrom • 35
3. Flynn JT. Metabolic syndrome as a predictor of
cardiovascular risk in children and adolescents. Am J
Hypertens 2007; 20: 883.
4. Cruz ML, Goran MI. The metabolic syndrome in children
and adolescents. Curr Diab Rep 2004; 4: 53-62.
5. Daniels SR, Arnett DK, Eckel RH, et al. Overweight
in children and adolescents: pathophysiology,
consequences, prevention, and treatment. Circulation
2005; 111: 1999-2012.
6. Neyzi O, Günöz H, Furman A ve ark. Türk çocuklarında
vücut ağırlığı, boy uzunluğu, baş çevresi ve vücut kitle
indeksi referans değerleri. Çocuk Sağlığı ve Hastalıkları
Dergisi 2008; 51: 1-14.
7. Lee PA, Houk CP. Puberty and its Disorders. In: Lifshitz
F (ed). Pediatric Endocrinology. 5th ed. New York:
Informa Healthcare, 2007: 275.
8. National High Blood Pressure Education Program
Working Group on High Blood Pressure in Children
and Adolescents. The fourth report on the diagnosis,
evaluation, and treatment of high blood pressure
in children and adolescents. Pediatrics 2004; 114:
555-576.
9. National Cholesterol Education Program (NCEP):
highlights of the report of the Expert Panel on Blood
Cholesterol Levels in Children and Adolescents.
Pediatrics 1992; 89: 495-501.
10. Tershakovec AM, Rader DJ. Disorders of lipoprotein
metabolism and transport. In: Behrman RE, Kliegman
RM, Jenson HB (eds). Nelson Textbook of Pediatrics.
17th ed. Philadelphia: Elsevier Science, 2004: 448.
11. Rosenbloom AL. Diabetes diagnosis in the child and
adolescent: diagnosis and classification. In: Lifshitz
F (ed). Pediatric Endocrinology. 5th ed. New York:
Informa Healthcare, 2007: 58.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA,
Treacher DF, Turner RC. Homeostasis model assessment:
insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man.
Diabetologia 1985; 28: 412-419.
13. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C.
Homeostasis model assessment is more reliable than the
fasting glucose/insulin ratio and quantitative insulin
sensitivity check index for assessing insulin resistance
among obese children and adolescents. Pediatrics 2005;
115: 500-503.
14. Singh GK. Metabolic syndrome in children and
adolescents. Curr Treat Options Cardiovasc Med 2006;
8: 403-413.
15. Reinehr T, de Sousa G, Andler W. Longitudinal
analyses among overweight, insulin resistance, and
cardiovascular risk factors in children. Obes Res 2005;
13: 1824-1833.
16. Atabek ME, Pirgon O. Assessment of insulin sensitivity
from measurements in fasting state and during an
oral glucose tolerance test in obese children. J Pediatr
Endocrinol Metab 2007; 20: 187-195.
17. Atabek ME, Pirgon O, Kurtoglu S. Prevalence of
metabolic syndrome in obese Turkish children and
adolescents. Diabetes Res Clin Pract 2006; 72: 315-321.
18. Reaven GM. Banting Lecture. Role of insulin resistance
in human disease. Diabetes 1988; 37: 1595-1607.
19. Dhuper S, Cohen HW, Daniel J, et al. Utility of the
modified ATP III defined metabolic syndrome and
severe obesity as predictors of insulin resistance in
overweight children and adolescents: a cross-sectional
study. Cardiovasc Diabetol 2007; 6: 4.
20. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz
WH. Prevalence of a metabolic syndrome phenotype
in adolescents: findings from the third National Health
and Nutrition Examination Survey, 1988-1994. Arch
Pediatr Adolesc Med 2003; 157: 821-827.
21. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a
metabolic syndrome phenotype among U.S. adolescents,
1999-2000. Diabetes Care 2004; 27: 2438-2443.
22. Druet C, Dabbas M, Baltakse V, et al. Insulin resistance
and the metabolic syndrome in obese French children.
Clin Endocrinol (Oxf) 2006; 64: 672-678.
23. Calcaterra V, Klersy C, Muratori T, et al. Prevalence of
metabolic syndrome (MS) in children and adolescents
with varying degrees of obesity. Clin Endocrinol (Oxf)
2008; 68: 868-872.
24. López-Capapé M, Alonso M, Colino E, Mustieles C,
Corbatón J, Barrio R. Frequency of the metabolic
syndrome in obese Spanish pediatric population. Eur J
Endocrinol 2006; 155: 313-319.
25. Sen Y, Kandemir N, Alikasifoglu A, Gonc N, Ozon A.
Prevalence and risk factors of metabolic syndrome in
obese children and adolescents: the role of the severity
of obesity. Eur J Pediatr 2008; 10: 1183-1189.
26. Agirbasli M, Cakir S, Ozme S, Ciliv G. Metabolic
syndrome in Turkish children and adolescents.
Metabolism 2006; 55: 1002-1006

Thank you for copying data from http://www.arastirmax.com